Loading...
XJPX2796
Market cap38mUSD
Jan 09, Last price  
531.00JPY
1D
-2.21%
1Q
-15.71%
Jan 2017
0.57%
IPO
4.57%
Name

Pharmarise Holdings Corp

Chart & Performance

D1W1MN
XJPX:2796 chart
P/E
—
P/S
0.11
EPS
—
Div Yield, %
2.11%
Shrs. gr., 5y
-0.59%
Rev. gr., 5y
1.04%
Revenues
54.47b
+4.68%
18,576,785,00020,007,602,00023,416,897,00026,825,000,00029,607,057,00033,357,066,00038,221,039,00039,506,082,00048,511,570,00052,949,000,00054,562,000,00051,728,000,00051,030,000,00052,324,000,00051,608,000,00052,030,000,00054,466,000,000
Net income
-351m
L
96,525,000222,508,000276,576,000562,978,000685,818,000958,001,000369,094,000227,892,000382,195,0007,000,000-208,000,00023,000,000577,000,000426,000,000447,000,000333,000,000-351,000,000
CFO
2.71b
+7.70%
1,480,409,0001,272,516,000807,366,000942,417,0002,283,834,0001,618,239,0001,306,120,0003,405,093,000-272,758,0002,103,000,0001,330,000,000895,000,0001,572,000,0001,945,000,000713,000,0002,520,000,0002,714,000,000
Dividend
May 29, 20250 JPY/sh
Earnings
Mar 24, 2025

Profile

Pharmarise Holdings Corporation manages dispensing pharmacies in Japan. Its dispensing pharmacies provide patients with dispensing services based on prescriptions drawn up by medical institutions. The company also manages drug stores and convenience stores; and sells cosmetics. In addition, it is involved in the storage and management of medical examination records of patients on behalf of medical institutions; operation of medical mall; and provision of temporary help. As of May 31, 2021, the company operated 347 stores. Pharmarise Holdings Corporation was incorporated in 1984 and is headquartered in Tokyo, Japan.
URL
https://www.pharmarise.com/
IPO date
Feb 01, 2007
Employees
1,555
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑052023‑052022‑052021‑052020‑052019‑052018‑052017‑052016‑052015‑05
Income
Revenues
54,466,000
4.68%
52,030,000
0.82%
51,608,000
-1.37%
Cost of revenue
46,029,000
43,909,000
43,501,000
Unusual Expense (Income)
NOPBT
8,437,000
8,121,000
8,107,000
NOPBT Margin
15.49%
15.61%
15.71%
Operating Taxes
485,000
702,000
863,000
Tax Rate
5.75%
8.64%
10.65%
NOPAT
7,952,000
7,419,000
7,244,000
Net income
(351,000)
-205.41%
333,000
-25.50%
447,000
4.93%
Dividends
(127,000)
(131,000)
(131,000)
Dividend yield
1.87%
1.72%
1.45%
Proceeds from repurchase of equity
(340,000)
1,735,000
BB yield
5.01%
-19.23%
Debt
Debt current
2,831,000
3,677,000
2,490,000
Long-term debt
10,358,000
5,893,000
7,973,000
Deferred revenue
(42,000)
(31,000)
Other long-term liabilities
1,440,000
1,139,000
1,149,000
Net debt
5,805,000
2,820,000
4,333,000
Cash flow
Cash from operating activities
2,714,000
2,520,000
713,000
CAPEX
(619,000)
(542,000)
(466,000)
Cash from investing activities
(3,120,000)
(703,000)
(292,000)
Cash from financing activities
2,771,000
(1,072,000)
(1,034,000)
FCF
7,761,000
7,767,000
7,321,000
Balance
Cash
7,150,000
4,742,000
3,991,000
Long term investments
234,000
2,008,000
2,139,000
Excess cash
4,660,700
4,148,500
3,549,600
Stockholders' equity
5,813,000
5,643,000
5,379,000
Invested Capital
16,968,300
12,739,500
13,749,400
ROIC
53.53%
56.02%
53.96%
ROCE
39.01%
47.97%
46.78%
EV
Common stock shares outstanding
10,524
12,470
12,396
Price
645.00
5.56%
611.00
-16.07%
728.00
-6.06%
Market cap
6,787,992
-10.91%
7,619,229
-15.57%
9,024,605
-5.88%
EV
12,672,992
10,544,229
13,448,605
EBITDA
9,607,000
9,345,000
9,415,000
EV/EBITDA
1.32
1.13
1.43
Interest
66,000
55,000
65,000
Interest/NOPBT
0.78%
0.68%
0.80%